BioSpace News Archive

Geron Corporation, a late-stage clinical biopharmaceutical company, announced the appointment of Faye Feller, M.D., to Executive Vice President and Chief Medical Officer, effective July 9, 2022.

Aquestive Therapeutics, Inc. (NASDAQ: AQST), today announced positive topline results from the first three arms of Part 3 of the EPIPHAST study for its AQST-109 epinephrine oral film.

Bristol Myers Squibb (NYSE: BMY) today announced that its Board of Directors has elected Deepak L. Bhatt, M.D., MPH., to the Board, effective June 14, 2022.

Bristol Myers Squibb announced that its Board of Directors has declared a quarterly dividend of fifty-four cents per share on the $.10 par value common stock of the company.

Roivant Sciences (Nasdaq: ROIV), a biopharmaceutical company dedicated to improving the delivery of healthcare to patients, today announced that it will host a live conference call and webcast at 8:00 a.m. EDT on Tuesday, June 28, 2022 to report its financial results for the fourth quarter and fiscal year ended March 31, 2022 and provide a corporate update.

UroViu Corp has launched the new Hystero-V, a single-use hysteroscope compatible with UroViu’s Always Ready endoscopy platform.

Ascletis Pharma Inc. announces that the latest results of the Phase IIb clinical trial of ASC22 in patients with chronic hepatitis B will be presented at an oral parallel session of the International Liver Congress™ 2022 held by the European Association for the Study of the Liver in London on June 25, 2022.

Arcellx, Inc. announced the pricing of an upsized underwritten follow-on offering of 7,000,000 shares of common stock at a price to the public of $16.00 per share.